• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物地尔硫䓬代谢酶的结构提示了可能的底物结合模式。

Structure of a gut microbial diltiazem-metabolizing enzyme suggests possible substrate binding mode.

机构信息

School of Life Science, University of Science and Technology of China, Anhui, 230026, China; Industrial Enzymes National Engineering Laboratory, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China.

Institute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan.

出版信息

Biochem Biophys Res Commun. 2020 Jun 30;527(3):799-804. doi: 10.1016/j.bbrc.2020.04.116. Epub 2020 May 16.

DOI:10.1016/j.bbrc.2020.04.116
PMID:32423809
Abstract

When administrated orally, the vasodilating drug diltiazem can be metabolized into diacetyl diltiazem in the presence of Bacteroides thetaiotaomicron, a human gut microbe. The removal of acetyl group from the parent drug is carried out by the GDSL/SGNH-family hydrolase BT4096. Here the crystal structure of the enzyme was solved by mercury soaking and single-wavelength anomalous diffraction. The protein folds into two parts. The N-terminal part comprises the catalytic domain which is similar to other GDSL/SGNH hydrolases. The flanking C-terminal part is made up of a β-barrel subdomain and an α-helical subdomain. Structural comparison shows that the catalytic domain is most akin to acetyl-xylooligosaccharide esterase and allows a plausible binding mode of diltiazem to be proposed. The β-barrel subdomain is similar in topology to the immunoglobulin-like domains, including some carbohydrate-binding modules, of various bacterial glycoside hydrolases. Consequently, BT4096 might originally function as an oligosaccharide deacetylase with additional subdomains that could enhance substrate binding, and it acts on diltiazem just by accident.

摘要

当口服给予时,血管扩张药物地尔硫卓在人类肠道微生物拟杆菌的存在下可以代谢为二乙酰地尔硫卓。亲代药物的乙酰基的去除是由 GDSL/SGNH 家族水解酶 BT4096 完成的。在这里,通过汞浸泡和单波长异常衍射法解决了该酶的晶体结构。该蛋白质折叠成两部分。N 端部分包含催化结构域,与其他 GDSL/SGNH 水解酶相似。侧翼的 C 端部分由一个β桶亚结构域和一个α螺旋亚结构域组成。结构比较表明,催化结构域与乙酰基-木二糖酯酶最相似,并允许提出地尔硫卓的合理结合模式。β桶亚结构域在拓扑结构上与免疫球蛋白样结构域相似,包括各种细菌糖苷水解酶的一些糖结合模块。因此,BT4096 最初可能作为一种寡糖脱乙酰酶发挥作用,具有额外的亚结构域,可以增强底物结合,并且它只是偶然对地尔硫卓起作用。

相似文献

1
Structure of a gut microbial diltiazem-metabolizing enzyme suggests possible substrate binding mode.肠道微生物地尔硫䓬代谢酶的结构提示了可能的底物结合模式。
Biochem Biophys Res Commun. 2020 Jun 30;527(3):799-804. doi: 10.1016/j.bbrc.2020.04.116. Epub 2020 May 16.
2
Ascertaining the biochemical function of an essential pectin methylesterase in the gut microbe .确定肠道微生物中必需果胶甲酯酶的生化功能。
J Biol Chem. 2020 Dec 25;295(52):18625-18637. doi: 10.1074/jbc.RA120.014974. Epub 2020 Oct 23.
3
Structural and functional analyses of glycoside hydrolase 138 enzymes targeting chain A galacturonic acid in the complex pectin rhamnogalacturonan II.针对复杂果胶鼠李半乳糖醛酸聚糖 II 中链 A 半乳糖醛酸的糖苷水解酶 138 酶的结构和功能分析。
J Biol Chem. 2019 May 10;294(19):7711-7721. doi: 10.1074/jbc.RA118.006626. Epub 2019 Mar 15.
4
First crystal structure of an endo-levanase - the BT1760 from a human gut commensal Bacteroides thetaiotaomicron.内切葡聚糖酶 BT1760 的首个晶体结构——来自人类肠道共生拟杆菌的泰氏拟杆菌。
Sci Rep. 2019 Jun 11;9(1):8443. doi: 10.1038/s41598-019-44785-0.
5
An evolutionarily distinct family of polysaccharide lyases removes rhamnose capping of complex arabinogalactan proteins.一个在进化上独特的多糖裂解酶家族可去除复杂阿拉伯半乳聚糖蛋白的鼠李糖封端。
J Biol Chem. 2017 Aug 11;292(32):13271-13283. doi: 10.1074/jbc.M117.794578. Epub 2017 Jun 21.
6
Structure of a glycoside hydrolase family 50 enzyme from a subfamily that is enriched in human gut microbiome bacteroidetes.来自富含人类肠道微生物拟杆菌亚家族的糖苷水解酶家族50酶的结构
Proteins. 2017 Jan;85(1):182-187. doi: 10.1002/prot.25189. Epub 2016 Nov 4.
7
Complex pectin metabolism by gut bacteria reveals novel catalytic functions.肠道细菌复杂的果胶代谢揭示了新的催化功能。
Nature. 2017 Apr 6;544(7648):65-70. doi: 10.1038/nature21725. Epub 2017 Mar 22.
8
A surface endogalactanase in Bacteroides thetaiotaomicron confers keystone status for arabinogalactan degradation.拟杆菌属厚壁菌门表面内切半乳糖醛酸酶赋予了阿拉伯半乳聚糖降解的关键地位。
Nat Microbiol. 2018 Nov;3(11):1314-1326. doi: 10.1038/s41564-018-0258-8. Epub 2018 Oct 22.
9
Structural basis of mammalian high-mannose N-glycan processing by human gut Bacteroides.哺乳动物高甘露糖 N-聚糖加工的结构基础由人类肠道拟杆菌完成。
Nat Commun. 2020 Feb 14;11(1):899. doi: 10.1038/s41467-020-14754-7.
10
Crystal structure of Escherichia coli thioesterase I/protease I/lysophospholipase L1: consensus sequence blocks constitute the catalytic center of SGNH-hydrolases through a conserved hydrogen bond network.大肠杆菌硫酯酶I/蛋白酶I/溶血磷脂酶L1的晶体结构:共有序列模块通过保守的氢键网络构成SGNH水解酶的催化中心。
J Mol Biol. 2003 Jul 11;330(3):539-51. doi: 10.1016/s0022-2836(03)00637-5.

引用本文的文献

1
Gut microbiome and inflammation in cardiovascular drug response: trends in therapeutic success and commercial focus.肠道微生物群与心血管药物反应中的炎症:治疗成功趋势与商业焦点
Inflammopharmacology. 2025 Jan;33(1):49-68. doi: 10.1007/s10787-024-01593-x. Epub 2024 Nov 2.
2
Pharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response.药物生态学:肠道微生物群如何导致药物反应的差异。
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):355-373. doi: 10.1146/annurev-pharmtox-022724-100847. Epub 2024 Dec 17.
3
Novel Techniques and Models for Studying the Role of the Gut Microbiota in Drug Metabolism.
研究肠道微生物群在药物代谢中作用的新方法和模型。
Eur J Drug Metab Pharmacokinet. 2024 Mar;49(2):131-147. doi: 10.1007/s13318-023-00874-0. Epub 2023 Dec 21.
4
Prophage-Derived Regions in Genomes: Good Things, Small Packages.基因组中的噬菌体衍生区域:小而美。
Int J Mol Sci. 2023 Jan 13;24(2):1586. doi: 10.3390/ijms24021586.
5
RRLC-QTOF/MS-Based Metabolomics Reveal the Mechanism of Chemical Variations and Transformations of Astragali Radix as a Result of the Roasting Process.基于快速液相色谱-四极杆飞行时间质谱联用技术的代谢组学揭示黄芪在炮制过程中化学成分变化及转化的机制
Front Chem. 2022 May 5;10:903168. doi: 10.3389/fchem.2022.903168. eCollection 2022.
6
Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.药物微生物组学:在抗高血压治疗中利用药物与微生物群的相互作用
Front Med (Lausanne). 2022 Jan 19;8:742394. doi: 10.3389/fmed.2021.742394. eCollection 2021.